Relevium Technologies Completes Shares-For-Debt Transactions
01 oct. 2021 14h47 HE
|
Relevium Technologies Inc
MONTREAL, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that it has completed...
Relevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in Shares
10 août 2021 09h48 HE
|
Relevium Technologies Inc
MONTREAL, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has received conditional...
Relevium Announces Settlement of the Outstanding Notes
30 juin 2021 11h19 HE
|
Relevium Technologies Inc
MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today it has reached an agreement to...
Relevium Announces Shareholder Townhall and Conference Call
15 juin 2021 10h11 HE
|
Relevium Technologies Inc
MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...
Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders
10 juin 2021 08h11 HE
|
Relevium Technologies Inc
MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today the maturity of its...
Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation
20 mai 2021 02h00 HE
|
Relevium Technologies Inc
MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves
05 mai 2021 09h47 HE
|
Relevium Technologies Inc
MONTREAL, May 05, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), whose primary mandate is to focus on...
Biocannabix Enters Into LOI With IAM Health GmbH
29 avr. 2021 09h12 HE
|
Relevium Technologies Inc
MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April
11 mars 2021 13h59 HE
|
Relevium Technologies Inc
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the company has...
Relevium Announces Investor Relations Conference Call
04 févr. 2021 16h48 HE
|
Relevium Technologies Inc
MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...